Total Valuation
CareRx has a market cap or net worth of $154.68M. The enterprise value is $304.96.
Market Cap$154.68M
Enterprise Value$304.96
Share Statistics
CareRx has 63,514,038 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding63,514,038
Owned by Insiders10.96%
Owned by Institutions―
Financial Efficiency
CareRx’s return on equity (ROE) is 0.24 and return on invested capital (ROIC) is 6.01%.
Return on Equity (ROE)0.24
Return on Assets (ROA)0.10
Return on Invested Capital (ROIC)6.01%
Return on Capital Employed (ROCE)0.06
Revenue Per Employee241.51K
Profits Per Employee17.04K
Employee Count1,533
Asset Turnover1.46
Inventory Turnover15.82
Valuation Ratios
The current PE Ratio of CareRx is 7.9. CareRx’s PEG ratio is -0.01.
PE Ratio7.9
PS Ratio0.65
PB Ratio2.19
Price to Fair Value2.19
Price to FCF10.92
Price to Operating Cash Flow7.65
PEG Ratio-0.01
Income Statement
In the last 12 months, CareRx had revenue of 370.24M and earned 26.13M in profits. Earnings per share was 0.42.
Revenue370.24M
Gross Profit92.63M
Operating Income11.88M
Pretax Income3.35M
Net Income26.13M
EBITDA28.53M
Earnings Per Share (EPS)0.42
Cash Flow
In the last 12 months, operating cash flow was 27.40M and capital expenditures -3.60M, giving a free cash flow of 23.80M billion.
Operating Cash Flow27.40M
Free Cash Flow23.80M
Free Cash Flow per Share0.37
Dividends & Yields
CareRx pays an annual dividend of $0.016, resulting in a dividend yield of 2.26%
Dividend Per Share$0.016
Dividend Yield2.26%
Payout Ratio18.72%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.05
52-Week Price Change26.31%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
CareRx upcoming earnings date is Nov 11, 2026, After Close (Confirmed).
Last Earnings DateJul 29, 2026
Next Earnings DateNov 11, 2026
Ex-Dividend Date―
Financial Position
CareRx as a current ratio of 1.06, with Debt / Equity ratio of 70.78%
Current Ratio1.06
Quick Ratio0.78
Debt to Market Cap0.17
Net Debt to EBITDA2.23
Interest Coverage Ratio1.74
Taxes
In the past 12 months, CareRx has paid -22.77M in taxes.
Income Tax-22.77M
Effective Tax Rate-6.79
Enterprise Valuation
CareRx EV to EBITDA ratio is 10.63, with an EV/FCF ratio of 13.81.
EV to Sales0.82
EV to EBITDA10.63
EV to Free Cash Flow13.81
EV to Operating Cash Flow11.01
Balance Sheet
CareRx has $10.05M in cash and marketable securities with $76.33M in debt, giving a net cash position of -$66.28M billion.
Cash & Marketable Securities$10.05M
Total Debt$76.33M
Net Cash-$66.28M
Net Cash Per Share-$1.04
Tangible Book Value Per Share$0.17
Margins
Gross margin is 26.47%, with operating margin of 3.21%, and net profit margin of 7.06%.
Gross Margin26.47%
Operating Margin3.21%
Pretax Margin0.91%
Net Profit Margin7.06%
EBITDA Margin7.71%
EBIT Margin2.75%
Analyst Forecast
The average price target for CareRx is $3.75, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$3.75
Price Target Upside54.76% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast3.91%
EPS Growth Forecast―